SlideShare a Scribd company logo
•Dr. Reddy's Laboratories
Dr. Reddy was an Indian entrepreneur in the
pharmaceutical industry, the founder-chairman of Dr.
Reddy's Laboratories, which he established in 1984, and
chairman of Dr Reddy's Foundation (DRF), the corporate
social responsibility arm of the group, established 1996.The
Government of India, honoured him with the Padma Shri in
2001 and followed it up, later, with the Padmabhushan, for
his contribution to the Indian Pharmaceutical industry. He
was a member of the Indian Prime Minister's Council on
Trade and Industry.
• Reddy after graduating from the local high school,
went on to get his first Bachelor of science degree
from Andhra Christian College or A.C. College at
Guntur in 1958. Thereafter he, did his BSc-Tech in
Pharmaceuticals and Fine chemicals from UDCT,
Mumbai followed by a PhD in chemical
engineering from the National Chemical
Laboratory, Pune in 1969.
COMPANY BACKGROUND
• Dr.Reddy’s Laboratories Ltd founded in 1984 by
Dr k.Angi Reddy has become India’s second
biggest pharmaceutical company and its
headquartered is in Hyderabad.
• It produces and sells active pharmaceutical
ingredients , finished dosages and biologics.
• It manufactures ulcer medicines, antibiotics, pain
relievers, antidepressants and cardiovascular
drugs.
• ON 11April 2001, Dr Reddy’s became the first
pharmaceutical company from Asia Pacific to be
listed on Newyork stock exchange.
• The company carries out research and
development in diabetes, cancer, cardiovascular
diseases and bacterial infections.
• The company has over 120 medications and 60
active pharmaceutical ingredients for drug
manufacture.
• Dr Reddy’s market its product in approximately
100 countries , focusing on Europe, India,US and
Russia.
• The company employed over 8255 personnel,
• In 1997 it became the first Indian company to
out-license an original molecule (DRF 2593).
• Its revenue for 2006 - 2007 amounted to $ 1.5
billion, an increase of 24.3% of the previous year
. Its net income amounts to $ 216 million.
Company history
• Dr. Reddy's originally launched in 1984 producing
active pharmaceutical ingredients. In 1986,
Reddy's started operations on branded
formulations. Within a year Reddy's had launched
Norilet, the company's first recognized brand in
India. Soon, Dr. Reddy's obtained another success
with Omez, its branded omeprazole – ulcer and
reflux oesophagitis medication – launched at half
the price of other brands on the Indian market at
that time.
• Within a year, Reddy's became the first Indian
company to export the active ingredients for
pharmaceuticals to Europe. In 1987, Reddy's
started to transform itself from a supplier of
pharmaceutical ingredients to other
manufacturers into a manufacturer of
pharmaceutical products.
Dr.Reddy's began as a supplier to Indian drug manufacturers,
but it soon started exporting to other less-regulated markets
that had the advantage of not having to spend time and
money on a manufacturing plant that would gain approval
from a drug licensing body such as the U.S. Food and Drug
Administration (FDA). By the early 1990s, the expanded scale
and profitability from these unregulated markets enabled the
company to begin focusing on getting approval from drug
regulators for their formulations and bulk drug manufacturing
plants in more-developed economies.
Baceuticalngredients in India and seven FDA-inspected and ISO 9001
(quality) and ISO 14001 (environmental management) certified plants
m In 2010, the family-controlled Dr Reddy's denied
that it was in talks to sell its generics business in
India to US pharmaceutical giant Pfizer, which had
been suing the company for alleged patent
infringement after Dr Reddy's announced that it
intended to produce a generic version of
atorvastatin, marketed by Pfizer as Lipitor, an anti-
cholesterol medication. Reddy's was already linked
to UK pharmaceuticals multinational Glaxo
Smithkline.
In other European countries
• Apart from subsidiaries in Germany and UK ,
Dr.Reddy’s has agreements in following
European countries.
• DENMARK
• IRELAND
• NETHERLANDS
Factors for success
• Controlling the entire value chain
• Implementations of efficient new product
development processes
• High standard of corporate governance
Implementations of efficient new
product development processes
• Targeting the streamlining of new product
development process, Dr. Reddy’s implemented
project ‘racha’ using Microsoft accelerator for six
sigma. This is helping the company in taking key
decisions to launch the right products in the
market at the appropriate time.
High standard of corporate
governance
• Dr.Reddy’s adherence to high standard
of corporate governance and ethical
business practices has been a key factor
to its success. The mutual trust has
ensured greater success for the company.
Future plans
• Having acquired Betapharm, one of the fastest
growing generic companies in Germany over the
past 5 years, Dr.Reddy’s aims at leveraging this
strategic investment to evolve into a mid-sized
global pharmaceutical company. Dr.Reddy’s aims
to increase its revenue substantially and
improve its operating margin.
Dr. Reddy's starts clinical trials for CD
TNN Feb 8, 2005, 12.43am IST
• HYDERABAD: Dr Reddy's Laboratories has initiated
Phase I clinical trials for its cardiovascular drug
candidate RUS 3108. They are being conducted in
Belfast, Ireland. The phase I trials will explore the
safety and pharmacokinetic profiles of this drug
candidate in humans.
• This is the first time the company is testing a drug in
Europe. RUS 3108 is being developed for the
treatment of atherosclerosis, the major cause of heart
attacks and strokes. There are currently no drugs that
directly treat atherosclerosis.
• According to a company statement, the drug
represents a new approach to the treatment of
atherosclerosis. The RUS 3108 works by
affecting multiple pathways involved in the
disease like inflammation, proliferation and
thrombosis by inducing a protein called
perlecan.
• Company scientists have determined that
regulating the expression of perlecan can
provide direct protection against the disease.
• Uday Saxena, chief scientific officer of Dr Reddy's
said, "RUS 3108 represents a unique approach
for treatment of cardiovascular diseases, a
growing unmet medical need worldwide."
• Dr Reddy's conducts its drug discovery research
in Hyderabad and Atlanta and has discovery
programmes in the areas of diabetes,
cardiovascular, anti-infectives, inflammation and
cancer. The company currently has six new
chemical entities at various stages of clinical
development
Clinical Research Associate Jobs in Dr.
Reddy's
Internal : QA, Pharmacovigilence,
Medical writing, Medico Marketing, Data Management,,
Quality Check, Medical, Clinical Research Associate,
Regulatory, Formulation Development and Medico-
marketing teams
External : Site Investigators, CRO
job as QUALITY ASSURANCE
• EXPERIENCE: 4-8 years
• EDUCATION: M.SC./B.SC
Experience in handling IPQA/ Validation and
training activities in quality assurance
department of a pharnaceutical plant(OSD,
Ointment/ Injectables).
 Our Purpose
WE ACCELERATE ACCESS TO AFFORDABLE AND
INNOVATIVE MEDICINES
TOP RANKING IN INDIA
• A vast range of pharmaceutical products are offered
by Dr. Reddy's Labs. It has 60 APIs and 190
medications to treat various kinds of ailments. It is
now India's third largest pharmaceutical company in
terms of market capitalisation, which was valued at Rs.
56,638.13 crore on 15 June 2015. Its products and
services may be categorised as below:
• Generic Formulations
• Active Ingredients
• Pharmaceutical Services
• Biosimilars
• Propriety Product
Laboratories Aims
at making the lives of the individuals healthier and happier.
This company is one of the most popular pharmaceutical
companies with base in more than 100 countries. The
medicines of Dr. Reddy's Laboratories Limited are easily
available all across the globe.
Dr. Reddy's Pharmaceutical Company is very much
customer friendly. It takes care of the fact that maximum
people get benefited by the products of this
pharmaceutical company. It commercialized various
treatments so as to provide high tech treatment to the
masses. It tries to meet the medical needs of the people.
Though Dr. Reddy's Laboratories is located in various parts
of the world, it has its headquarters in India. This global
pharmaceutical company can be found over 100 countries.
The subsidiaries of this company are found at various
countries like US, Germany, UK, Russia and Brazil. 16
countries have the representative offices of Dr. Reddy's
Laboratories Limited. 21 countries have third party
distribution. It is one of the prestigious companies to be
listed in NYSE.
It is because of the best quality products and wide reach of
its medicines that it gives a tough competition to other
pharmaceutical companies. It has already left a mark in the
global pharmaceutical market.
Dr. Reddy's Pharmaceutical Company has some set values
that make it stand out among all pharmaceutical
companies. These include:
 Quality
 Harmony and social responsibility
 Respect for the individual
 Collaboration and team work
 Innovation and continuous learning
CONTACT
• Contact Details of Dr. Reddy's Laboratories
• Corporate Office
• Dr. Reddy's Laboratories Ltd.
• Greenlands, Ameerpet,
• Hyderabad 500 016, INDIA
• Tel: +91-40-23731946-50
• Fax: +91-40-23731955
• Visit: www.drreddys.com
Dr Reddy's Zoloft generic case
dismissed in USA
• India-headquartered Dr Reddy's Laboratories says that a
District Court for the state of New Jersey, USA, has declined
to hear the company's suit seeking a judgement that would
allow it to market a generic version of Pfizer's
antidepressant Zoloft (sertraline).
• Dr Reddy's filed an application for approval of the
compound with the US Food and Drug Administration in
25mg, 50mg and 100mg tablet forms, and was seeking a
decision on whether its generic version infringed Pfizer's
branded product after the latter firm failed to lodge a suit
against it within the 45-day period granted under current
regulations.
• The case was dismissed on the basis that Pfizer
required more time to examine if an
infringement had taken place. Dr Reddy's
responded by saying that it intended to provide
Pfizer with whatever information it needed and,
if necessary, renew its suit thereafter.
Dr. Reddy’s statement on the receipt of Warning Letter
from US FDA
Dr. Reddy’s Laboratories ( BSE: 500124 / NSE: DRREDDY /
NYSE: RDY ) today issued a statement acknowledging that it
has received a warning letter issued by the US FDA dated
November 05, 2015 relating to its API manufacturing
facilities at Srikakulam, Andhra Pradesh and Miryalaguda,
Telangana, as well as Oncology Formulation manufacturing
facility at duvvada, Visakhapatnam, Andhra Pradesh. This
action follows the earlier inspections of these sites by the
agency in November 2014, January 2015 and February 2015
respectively.
• Dr. Reddy’s CEO, G V Prasad commented “We take
quality and compliance matters seriously and stand by
our commitment to fully comply with the cGMP quality
standards across all of our facilities We will respond
comprehensive plan to address these observations
within the stipulated time-frame of 15 days. We will
continue to actively engage with the agency to resolve
these issues and we have also embarked on an initiative
to revamp our quality systems and processes, as an
organization - wide priority.
 Employee Reviews
 “ Good Place to Work ”
 “Good company, growth depends on department head ”
 “Great Place to learn the business nuances of Pharma at the
start of career.... ”
Amazing opportunities but highly challenging ”
“Quality assurance ”
Presented by  buddhabhushan reddy.new
Presented by  buddhabhushan reddy.new
Presented by  buddhabhushan reddy.new

More Related Content

What's hot

Analysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical IndustryAnalysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical Industry
HinduReddyAnumula
 
Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun Pharmaceuticals
Aman Dube
 
Product Mix of Dr. Reddy's
Product Mix of Dr. Reddy'sProduct Mix of Dr. Reddy's
Product Mix of Dr. Reddy'sAnimesh Gupta
 
Mankind corporate presentation
Mankind corporate presentationMankind corporate presentation
Mankind corporate presentation
Ankit Khandelewal
 
Drl analysis
Drl analysisDrl analysis
Drl analysis
Bibhu Prasad
 
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...
TilikaChawda
 
Overview of the Pharma industry
Overview of the Pharma industryOverview of the Pharma industry
Overview of the Pharma industrykeyursavalia
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
sridivyaannavarapu
 
Dr.reddy
Dr.reddyDr.reddy
Dr.reddy
dubey3016
 
Glenmark analyst ppt
Glenmark analyst pptGlenmark analyst ppt
Glenmark analyst ppt
Kevin Simon
 
Project report titles for mba in pharma
Project report titles for mba in pharmaProject report titles for mba in pharma
Project report titles for mba in pharma
mbaprojectconsultacy2014
 
Sun Pharma
Sun Pharma Sun Pharma
Sun Pharma
vaishnavi suvarna
 
Sun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin PharmaSun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin Pharma
Anmol Misal
 
Report on cipla
Report on ciplaReport on cipla
Report on cipla
mounika rayapati
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt finalSuraj Warthy
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
Sabarinath Suryaprakash
 
Mergers and Acquisitions in Indian Pharma Industry
Mergers and Acquisitions in Indian Pharma IndustryMergers and Acquisitions in Indian Pharma Industry
Mergers and Acquisitions in Indian Pharma Industry
Naveen Kumar
 
Cipla ppt presentation By Ajit R. Kulkarni
Cipla ppt presentation By Ajit R. KulkarniCipla ppt presentation By Ajit R. Kulkarni
Cipla ppt presentation By Ajit R. Kulkarni
Ajit Kulkarni
 

What's hot (20)

Analysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical IndustryAnalysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical Industry
 
Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun Pharmaceuticals
 
Product Mix of Dr. Reddy's
Product Mix of Dr. Reddy'sProduct Mix of Dr. Reddy's
Product Mix of Dr. Reddy's
 
Mankind corporate presentation
Mankind corporate presentationMankind corporate presentation
Mankind corporate presentation
 
Drl analysis
Drl analysisDrl analysis
Drl analysis
 
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...
 
Overview of the Pharma industry
Overview of the Pharma industryOverview of the Pharma industry
Overview of the Pharma industry
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
 
Dr.reddy
Dr.reddyDr.reddy
Dr.reddy
 
Glenmark analyst ppt
Glenmark analyst pptGlenmark analyst ppt
Glenmark analyst ppt
 
Project report titles for mba in pharma
Project report titles for mba in pharmaProject report titles for mba in pharma
Project report titles for mba in pharma
 
Sun Pharma
Sun Pharma Sun Pharma
Sun Pharma
 
Sun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin PharmaSun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin Pharma
 
Report on cipla
Report on ciplaReport on cipla
Report on cipla
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt final
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
 
Sun pharma ppt
Sun pharma pptSun pharma ppt
Sun pharma ppt
 
OS FINAL
OS FINALOS FINAL
OS FINAL
 
Mergers and Acquisitions in Indian Pharma Industry
Mergers and Acquisitions in Indian Pharma IndustryMergers and Acquisitions in Indian Pharma Industry
Mergers and Acquisitions in Indian Pharma Industry
 
Cipla ppt presentation By Ajit R. Kulkarni
Cipla ppt presentation By Ajit R. KulkarniCipla ppt presentation By Ajit R. Kulkarni
Cipla ppt presentation By Ajit R. Kulkarni
 

Similar to Presented by buddhabhushan reddy.new

Strategic Management Group Presentation
Strategic Management Group PresentationStrategic Management Group Presentation
Strategic Management Group Presentation
JOEL SABU
 
Dr reddy
Dr reddyDr reddy
Dr reddy
PINNUNAGARAJU
 
1
11
Bhavna final
Bhavna finalBhavna final
Bhavna final
bhavna0789
 
Pharma contract manufacturing companies in india
Pharma contract manufacturing companies in india Pharma contract manufacturing companies in india
Pharma contract manufacturing companies in india
AditiMehra14
 
Case study.pptx
Case study.pptxCase study.pptx
Case study.pptx
AnadiJangra
 
Pharma third party manufacturing companies in Baddi | Pharmaadda
Pharma third party manufacturing companies in Baddi | PharmaaddaPharma third party manufacturing companies in Baddi | Pharmaadda
Pharma third party manufacturing companies in Baddi | Pharmaadda
AditiMehra14
 
Top generic pharma companies in india ppt
Top generic pharma companies in india pptTop generic pharma companies in india ppt
Top generic pharma companies in india ppt
AditiMehra14
 
top 10 Pharma industry 2020
top 10 Pharma industry 2020top 10 Pharma industry 2020
top 10 Pharma industry 2020
Ashish Chaurasia
 
Top 10 pharma companies in haridwar | Pharmaadda
Top 10 pharma companies in haridwar | PharmaaddaTop 10 pharma companies in haridwar | Pharmaadda
Top 10 pharma companies in haridwar | Pharmaadda
AditiMehra14
 
List of pharma companies in Dehradun | Pharmaadda
List of pharma companies in Dehradun | PharmaaddaList of pharma companies in Dehradun | Pharmaadda
List of pharma companies in Dehradun | Pharmaadda
AditiMehra14
 
Top pharma tablets manufacturer in india ppt
Top pharma tablets manufacturer in india pptTop pharma tablets manufacturer in india ppt
Top pharma tablets manufacturer in india ppt
AditiMehra14
 
Business development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptxBusiness development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptx
dmrjput
 
Ranbaxycompanyprofile
Ranbaxycompanyprofile Ranbaxycompanyprofile
Ranbaxycompanyprofile bhawna allagh
 
Summer Internship Report
Summer Internship ReportSummer Internship Report
Summer Internship ReportPramod Patidar
 
0601015 training & development
0601015 training & development0601015 training & development
0601015 training & development
Supa Buoy
 
NARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADNARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABAD
jitharadharmesh
 
0601015 training & development
0601015 training & development0601015 training & development
0601015 training & development
Supa Buoy
 
Top 10 pharma manufacturers in baddi
Top 10 pharma manufacturers in baddiTop 10 pharma manufacturers in baddi
Top 10 pharma manufacturers in baddi
Aditi Mahajan
 

Similar to Presented by buddhabhushan reddy.new (20)

Strategic Management Group Presentation
Strategic Management Group PresentationStrategic Management Group Presentation
Strategic Management Group Presentation
 
Dr reddy
Dr reddyDr reddy
Dr reddy
 
1
11
1
 
Bhavna final
Bhavna finalBhavna final
Bhavna final
 
Pharma contract manufacturing companies in india
Pharma contract manufacturing companies in india Pharma contract manufacturing companies in india
Pharma contract manufacturing companies in india
 
Case study.pptx
Case study.pptxCase study.pptx
Case study.pptx
 
Pharma third party manufacturing companies in Baddi | Pharmaadda
Pharma third party manufacturing companies in Baddi | PharmaaddaPharma third party manufacturing companies in Baddi | Pharmaadda
Pharma third party manufacturing companies in Baddi | Pharmaadda
 
Top generic pharma companies in india ppt
Top generic pharma companies in india pptTop generic pharma companies in india ppt
Top generic pharma companies in india ppt
 
top 10 Pharma industry 2020
top 10 Pharma industry 2020top 10 Pharma industry 2020
top 10 Pharma industry 2020
 
Top 10 pharma companies in haridwar | Pharmaadda
Top 10 pharma companies in haridwar | PharmaaddaTop 10 pharma companies in haridwar | Pharmaadda
Top 10 pharma companies in haridwar | Pharmaadda
 
List of pharma companies in Dehradun | Pharmaadda
List of pharma companies in Dehradun | PharmaaddaList of pharma companies in Dehradun | Pharmaadda
List of pharma companies in Dehradun | Pharmaadda
 
Top pharma tablets manufacturer in india ppt
Top pharma tablets manufacturer in india pptTop pharma tablets manufacturer in india ppt
Top pharma tablets manufacturer in india ppt
 
Business development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptxBusiness development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptx
 
Ranbaxycompanyprofile
Ranbaxycompanyprofile Ranbaxycompanyprofile
Ranbaxycompanyprofile
 
Summer Internship Report
Summer Internship ReportSummer Internship Report
Summer Internship Report
 
0601015 training & development
0601015 training & development0601015 training & development
0601015 training & development
 
NARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADNARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABAD
 
0601015 training & development
0601015 training & development0601015 training & development
0601015 training & development
 
Top 10 pharma manufacturers in baddi
Top 10 pharma manufacturers in baddiTop 10 pharma manufacturers in baddi
Top 10 pharma manufacturers in baddi
 
Ranbaxy
RanbaxyRanbaxy
Ranbaxy
 

Recently uploaded

Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

Presented by buddhabhushan reddy.new

  • 1.
  • 3.
  • 4.
  • 5. Dr. Reddy was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group, established 1996.The Government of India, honoured him with the Padma Shri in 2001 and followed it up, later, with the Padmabhushan, for his contribution to the Indian Pharmaceutical industry. He was a member of the Indian Prime Minister's Council on Trade and Industry.
  • 6. • Reddy after graduating from the local high school, went on to get his first Bachelor of science degree from Andhra Christian College or A.C. College at Guntur in 1958. Thereafter he, did his BSc-Tech in Pharmaceuticals and Fine chemicals from UDCT, Mumbai followed by a PhD in chemical engineering from the National Chemical Laboratory, Pune in 1969.
  • 7.
  • 8. COMPANY BACKGROUND • Dr.Reddy’s Laboratories Ltd founded in 1984 by Dr k.Angi Reddy has become India’s second biggest pharmaceutical company and its headquartered is in Hyderabad. • It produces and sells active pharmaceutical ingredients , finished dosages and biologics. • It manufactures ulcer medicines, antibiotics, pain relievers, antidepressants and cardiovascular drugs.
  • 9. • ON 11April 2001, Dr Reddy’s became the first pharmaceutical company from Asia Pacific to be listed on Newyork stock exchange. • The company carries out research and development in diabetes, cancer, cardiovascular diseases and bacterial infections. • The company has over 120 medications and 60 active pharmaceutical ingredients for drug manufacture.
  • 10. • Dr Reddy’s market its product in approximately 100 countries , focusing on Europe, India,US and Russia. • The company employed over 8255 personnel, • In 1997 it became the first Indian company to out-license an original molecule (DRF 2593). • Its revenue for 2006 - 2007 amounted to $ 1.5 billion, an increase of 24.3% of the previous year . Its net income amounts to $ 216 million.
  • 11. Company history • Dr. Reddy's originally launched in 1984 producing active pharmaceutical ingredients. In 1986, Reddy's started operations on branded formulations. Within a year Reddy's had launched Norilet, the company's first recognized brand in India. Soon, Dr. Reddy's obtained another success with Omez, its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the Indian market at that time.
  • 12. • Within a year, Reddy's became the first Indian company to export the active ingredients for pharmaceuticals to Europe. In 1987, Reddy's started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products.
  • 13. Dr.Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies.
  • 14. Baceuticalngredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants m In 2010, the family-controlled Dr Reddy's denied that it was in talks to sell its generics business in India to US pharmaceutical giant Pfizer, which had been suing the company for alleged patent infringement after Dr Reddy's announced that it intended to produce a generic version of atorvastatin, marketed by Pfizer as Lipitor, an anti- cholesterol medication. Reddy's was already linked to UK pharmaceuticals multinational Glaxo Smithkline.
  • 15. In other European countries • Apart from subsidiaries in Germany and UK , Dr.Reddy’s has agreements in following European countries. • DENMARK • IRELAND • NETHERLANDS
  • 16. Factors for success • Controlling the entire value chain • Implementations of efficient new product development processes • High standard of corporate governance
  • 17. Implementations of efficient new product development processes • Targeting the streamlining of new product development process, Dr. Reddy’s implemented project ‘racha’ using Microsoft accelerator for six sigma. This is helping the company in taking key decisions to launch the right products in the market at the appropriate time.
  • 18. High standard of corporate governance • Dr.Reddy’s adherence to high standard of corporate governance and ethical business practices has been a key factor to its success. The mutual trust has ensured greater success for the company.
  • 19. Future plans • Having acquired Betapharm, one of the fastest growing generic companies in Germany over the past 5 years, Dr.Reddy’s aims at leveraging this strategic investment to evolve into a mid-sized global pharmaceutical company. Dr.Reddy’s aims to increase its revenue substantially and improve its operating margin.
  • 20. Dr. Reddy's starts clinical trials for CD TNN Feb 8, 2005, 12.43am IST • HYDERABAD: Dr Reddy's Laboratories has initiated Phase I clinical trials for its cardiovascular drug candidate RUS 3108. They are being conducted in Belfast, Ireland. The phase I trials will explore the safety and pharmacokinetic profiles of this drug candidate in humans. • This is the first time the company is testing a drug in Europe. RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of heart attacks and strokes. There are currently no drugs that directly treat atherosclerosis.
  • 21. • According to a company statement, the drug represents a new approach to the treatment of atherosclerosis. The RUS 3108 works by affecting multiple pathways involved in the disease like inflammation, proliferation and thrombosis by inducing a protein called perlecan. • Company scientists have determined that regulating the expression of perlecan can provide direct protection against the disease.
  • 22. • Uday Saxena, chief scientific officer of Dr Reddy's said, "RUS 3108 represents a unique approach for treatment of cardiovascular diseases, a growing unmet medical need worldwide." • Dr Reddy's conducts its drug discovery research in Hyderabad and Atlanta and has discovery programmes in the areas of diabetes, cardiovascular, anti-infectives, inflammation and cancer. The company currently has six new chemical entities at various stages of clinical development
  • 23. Clinical Research Associate Jobs in Dr. Reddy's Internal : QA, Pharmacovigilence, Medical writing, Medico Marketing, Data Management,, Quality Check, Medical, Clinical Research Associate, Regulatory, Formulation Development and Medico- marketing teams External : Site Investigators, CRO
  • 24. job as QUALITY ASSURANCE • EXPERIENCE: 4-8 years • EDUCATION: M.SC./B.SC Experience in handling IPQA/ Validation and training activities in quality assurance department of a pharnaceutical plant(OSD, Ointment/ Injectables).
  • 25.  Our Purpose WE ACCELERATE ACCESS TO AFFORDABLE AND INNOVATIVE MEDICINES
  • 26.
  • 27. TOP RANKING IN INDIA • A vast range of pharmaceutical products are offered by Dr. Reddy's Labs. It has 60 APIs and 190 medications to treat various kinds of ailments. It is now India's third largest pharmaceutical company in terms of market capitalisation, which was valued at Rs. 56,638.13 crore on 15 June 2015. Its products and services may be categorised as below: • Generic Formulations • Active Ingredients • Pharmaceutical Services • Biosimilars • Propriety Product
  • 28. Laboratories Aims at making the lives of the individuals healthier and happier. This company is one of the most popular pharmaceutical companies with base in more than 100 countries. The medicines of Dr. Reddy's Laboratories Limited are easily available all across the globe. Dr. Reddy's Pharmaceutical Company is very much customer friendly. It takes care of the fact that maximum people get benefited by the products of this pharmaceutical company. It commercialized various treatments so as to provide high tech treatment to the masses. It tries to meet the medical needs of the people.
  • 29. Though Dr. Reddy's Laboratories is located in various parts of the world, it has its headquarters in India. This global pharmaceutical company can be found over 100 countries. The subsidiaries of this company are found at various countries like US, Germany, UK, Russia and Brazil. 16 countries have the representative offices of Dr. Reddy's Laboratories Limited. 21 countries have third party distribution. It is one of the prestigious companies to be listed in NYSE.
  • 30. It is because of the best quality products and wide reach of its medicines that it gives a tough competition to other pharmaceutical companies. It has already left a mark in the global pharmaceutical market. Dr. Reddy's Pharmaceutical Company has some set values that make it stand out among all pharmaceutical companies. These include:  Quality  Harmony and social responsibility  Respect for the individual  Collaboration and team work  Innovation and continuous learning
  • 31. CONTACT • Contact Details of Dr. Reddy's Laboratories • Corporate Office • Dr. Reddy's Laboratories Ltd. • Greenlands, Ameerpet, • Hyderabad 500 016, INDIA • Tel: +91-40-23731946-50 • Fax: +91-40-23731955 • Visit: www.drreddys.com
  • 32. Dr Reddy's Zoloft generic case dismissed in USA • India-headquartered Dr Reddy's Laboratories says that a District Court for the state of New Jersey, USA, has declined to hear the company's suit seeking a judgement that would allow it to market a generic version of Pfizer's antidepressant Zoloft (sertraline). • Dr Reddy's filed an application for approval of the compound with the US Food and Drug Administration in 25mg, 50mg and 100mg tablet forms, and was seeking a decision on whether its generic version infringed Pfizer's branded product after the latter firm failed to lodge a suit against it within the 45-day period granted under current regulations.
  • 33. • The case was dismissed on the basis that Pfizer required more time to examine if an infringement had taken place. Dr Reddy's responded by saying that it intended to provide Pfizer with whatever information it needed and, if necessary, renew its suit thereafter.
  • 34. Dr. Reddy’s statement on the receipt of Warning Letter from US FDA Dr. Reddy’s Laboratories ( BSE: 500124 / NSE: DRREDDY / NYSE: RDY ) today issued a statement acknowledging that it has received a warning letter issued by the US FDA dated November 05, 2015 relating to its API manufacturing facilities at Srikakulam, Andhra Pradesh and Miryalaguda, Telangana, as well as Oncology Formulation manufacturing facility at duvvada, Visakhapatnam, Andhra Pradesh. This action follows the earlier inspections of these sites by the agency in November 2014, January 2015 and February 2015 respectively.
  • 35. • Dr. Reddy’s CEO, G V Prasad commented “We take quality and compliance matters seriously and stand by our commitment to fully comply with the cGMP quality standards across all of our facilities We will respond comprehensive plan to address these observations within the stipulated time-frame of 15 days. We will continue to actively engage with the agency to resolve these issues and we have also embarked on an initiative to revamp our quality systems and processes, as an organization - wide priority.
  • 36.  Employee Reviews  “ Good Place to Work ”  “Good company, growth depends on department head ”  “Great Place to learn the business nuances of Pharma at the start of career.... ” Amazing opportunities but highly challenging ” “Quality assurance ”